Korean Market
OTHR
GFC Life Science
★

GFC Life Science Grants 20,000 Stock Options to Key Personnel; Minor Dilution of 0.38%

 
MATR
GFC Life Science
★

GFC Life Science decides to sell 2,500 treasury shares to employees for compensation, negligible dilution

 
OWNR
GFC Life Science
★

GFC Life Science CEO Heecheol Kang increases stake by 0.09% via open market purchases, signaling management confidence

 
OWNR
GFC Life Science
★

Largest Shareholder Heecheol Kang Increases Stake by 0.09%p to 37.27% via Open Market Purchase

 
OWNR
GFC Life Science
★

GFC Life Science CEO Heecheol Kang Increases Stake by 9,100 Shares in Open Market Purchases, Ownership Rises to 32.68%

 
OWNR
GFC Life Science
★

Largest Shareholder Heecheol Kang Slightly Increases Stake via Open Market Purchase, Maintaining Management Influence Purpose

 
OWNR
GFC Life Science
★

Large Shareholding Change Report: Exercise of 21,674 Stock Options by Executive Lee Dong Hwan

 
OWNR
GFC Life Science
★

Executive Lee Dong-hwan Acquires 21,674 Shares (0.41%) via Stock Option Exercise

 
EXCH
GFC Life Science
★

IR Event Hosted by Daishin Securities on May 27, 2026

 
PERI
GFC Life Science
★★

GFC Life Science Reports Strong Q1 2026 Results with Revenue and Profit Growth, R&D Investment Expansion

 
OWNR
GFC Life Science
★★

Largest Shareholder & CEO Kang Hee-chul Open Market Purchase

 
OWNR
GFC Life Science
★★★

Largest Shareholder CEO Kang Hee-chul Acquires 5,423 Shares via Open Market Purchase